Related Experiment Video
Updated: May 12, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Transcatheter aortic valve implantation with a CoreValve bioprosthesis in a 57-year-old man
Mehmet Bilge1, Hatice Tolunay, Ayse Saatci Yasar
1Ataturk Education and Research Hospital, Cardiology Department, Ankara, Turkey.
Abstract:
Transcatheter aortic valve implantation (TAVI) is a promising new technology which is typically used to treat elderly patients with severe aortic stenosis who cannot undergo surgical aortic valve replacement due to high risk factors. This procedure may also be a therapeutic option in particular relatively young cases with severe symptomatic aortic stenosis who are unsuitable candidates for surgery. Clinical experience with TAVI in these patients is very limited due to concerns regarding long-term valve durability. Herein, the case is reported of a 57-year-old man with severe aortic stenosis who presented with decompensated heart failure and successfully underwent transfemoral CoreValve implantation. To the best of the present authors' knowledge, this is the youngest reported patient to have received a CoreValve bioprosthesis to date.
Related Concept Videos
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis III: Medical Management
Mitral Stenosis I: Introduction
Aortic Regurgitation III: Medical Management
Mitral Valve Prolapse I: Introduction
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
